Image For Activity Cover
Opioid and Other Substance Use Disorders
CME is offered through AMA directly, not AANEM.
Information
There are new DEA license requirements in the new Medication Access and Training (MATE) Act that was passed as part of the Consolidated Appropriations Act of 2023.

• All DEA-registered practitioners are responsible for satisfying a new, one-time, 8 hour training requirement on the treatment and management of patients with opioid or other substance use disorders.

• Beginning June 27, 2023, practitioners must have completed the one-time education requirement before applying for a DEA license for the first time or to have their DEA license renewed

Resources for providers:

Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered


2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

                   

© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
Powered By